A team of Cyprus-led scientists has made a breakthrough in understanding breast and ovarian cancer with a milestone study that distinguishes “innocent” and “dangerous” genetic errors, the Cyprus Institute of Neurology and Genetics (CING) announced on Tuesday.
The study, published in Nature Communications, marks significant progress in the diagnosis and assessment of danger regarding breast and ovarian cancer, allowing for the safer interpretation of mutations in the BRCA1 and BRCA2
